Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin in von Willebrand disease: biological versus clinical efficacy
2005-004496-38Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- May 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desmopressin in von Willebrand disease (VWD), sponsored by Rigshospitalet. Started May 2006; status: completed.
02
Drugs
desmopressin
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2005-004496-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004496-38.